Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
HopeAI has joined the Mayo Clinic Platform Accelerate program to enhance drug development using AI, as announced in a press release. This partnership allows HopeAI to access Mayo Clinic's real-world data platform, aiming to improve clinical trial design and efficiency.
EasyPA has introduced an AI-powered platform to address inefficiencies in the prior authorization process, ahead of the 2026 CMS deadline.
Atlas Meditech's ATLAS AI has demonstrated superior diagnostic capabilities compared to clinicians and ChatGPT in a recent study, achieving a 90% success rate.
Medallion has been named to the 2025 Inc. 5000 list, highlighting its rapid growth in AI-powered provider network infrastructure.
Highmark Health and Abridge have announced a collaboration to deploy AI technologies across their healthcare ecosystem, focusing on enhancing patient-clinician interactions and streamlining prior authorization processes.
Garden has launched BLOOM, a Markush structure search engine, to enhance AI drug design by providing real-time IP verification, as announced in a press release.
NESA's Virtual Care Platform has become the first inpatient virtual care solution to receive Epic's Toolbox designation, ensuring seamless integration with Epic's EHR system.
HistoIndex has introduced FibroSIGHT Plus, an AI-driven test for fibrosis assessment in the US, enhancing precision in diagnosing Metabolic Dysfunction-associated Steatohepatitis (MASH).
Body Vision Medical has received Pre-Market Approval from Singapore's Health Sciences Authority for its LungVision imaging platform, enhancing early lung cancer diagnosis.
Pager Health has launched an AI-powered Behavioral Health Agent to streamline access to mental health support, as announced in a press release.
ARMR Sciences Inc. has announced a $30 million capital raise to advance its biodefense platform against fentanyl and AI-driven synthetic drug threats, as stated in a press release.
Ellipsis Health has been selected as a key partner in the CMS Health Tech Ecosystem, focusing on AI-driven healthcare transformation.
Caris Life Sciences has published a study demonstrating the effectiveness of its AI-based tool, Caris GPSai, in improving cancer diagnosis accuracy, as announced in a press release.
Researchers at Yonsei University have developed MSI-SEER, an AI model that predicts microsatellite instability and tumor responsiveness to immune checkpoint inhibitors, announced in a press release.
CERTIFY Health and DentalBee have announced a partnership to automate dental workflows, enhancing practice efficiency and patient care.
Caris Life Sciences has published a study showing that their AI-based image analysis model significantly improves survival rates for breast cancer patients treated with checkpoint inhibitors.
Fluent has launched the Fluent Credentialing SaaS platform to streamline dental credentialing processes using AI and automation, as announced in a press release.
XtalPi and DoveTree Medicines have announced a strategic collaboration worth up to $6 billion to leverage AI and robotics in drug discovery, focusing on oncology, immunology, and other therapeutic areas.
SOPHiA GENETICS has announced an expanded partnership with AstraZeneca to leverage AI for improving breast cancer patient outcomes, as stated in a press release.
METiS Technologies has completed a RMB 400 million Series D financing round, co-led by Beijing Medical and Health Industry Investment Fund and Daxing Industrial Investment Fund, to advance its AI-driven nanodelivery platform.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
